Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Resmed Inc

NYSE: RMD · Industrial Applications and Services · 6 alerts · CIK 943819

Share price
$238.19Close, Nov 16
Market cap
$33.5B
Shares outstanding
140.66MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Resmed Inc filings on SEC EDGAR ↗

6:02 AM ET 10-Q
Financial Results ▶ Call

Resmed Q1 2026 Results: Net Income $418M, Up 20.0% YoY

ResMed Inc. reported a net revenue increase to $1.41 billion for the quarter ended September 30, 2026, compared to $1.34 billion in the prior year, driven by Sleep and Breathing Health products. Net income rose to $418.4 million, significantly aided by a $61.8 million gain from the divestment of subsidiaries.

Key figure
Net income $418M · +20.0% YoY
4:07 PM ET 8-K
Financial Results

Resmed Financial Results

ResMed reported Q1 fiscal year 2027 revenue of $1.4 billion, a 6% increase driven by global demand for sleep and breathing health solutions. The company returned over $1 billion to shareholders through dividends and share repurchases during the quarter, supported by strong free cash flow and the divestiture of MatrixCare.

Term
Q1 2027

“We began fiscal year 2027 with a strong first quarter, driven by continued global demand for our sleep and breathing health solutions and ongoing execution across our business. Year over year, we grew core constant currency revenue 7%, expanded non-GAAP gross margin by 50 basis points, and increased non-GAAP earnings per share by 14%.”

Mick Farrell, Resmed’s Chairman and CEO

“Looking ahead to the rest of fiscal year 2027, we will continue to build our core sleep and breathing health businesses by extending the reach of our digital health ecosystem and connecting more of the people worldwide who need care with life-saving treatment delivered right in their own home.”

Mick Farrell, Resmed’s Chairman and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.